Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.
about
Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions.Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection.Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC.How to treat borderline resectable pancreatic cancer: current challenges and future directions.
P2860
Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Induction Chemotherapy Followe ...... ced Pancreatic Adenocarcinoma.
@ast
Induction Chemotherapy Followe ...... ced Pancreatic Adenocarcinoma.
@en
type
label
Induction Chemotherapy Followe ...... ced Pancreatic Adenocarcinoma.
@ast
Induction Chemotherapy Followe ...... ced Pancreatic Adenocarcinoma.
@en
prefLabel
Induction Chemotherapy Followe ...... ced Pancreatic Adenocarcinoma.
@ast
Induction Chemotherapy Followe ...... ced Pancreatic Adenocarcinoma.
@en
P2093
P1476
Induction Chemotherapy Followe ...... ced Pancreatic Adenocarcinoma.
@en
P2093
Andrea Wang-Gillam
Andrew Y Lee
Christine O Menias
David C Linehan
Jeffrey R Olsen
Motoyo Yano
Parag J Parikh
Robert J Myerson
Shahed N Badiyan
Shariq Khwaja
P356
10.1097/COC.0000000000000003
P577
2013-11-22T00:00:00Z